microRNAs: a new class of endogenous antimicrobials for the treatment of infections in cystic fibrosis and beyond

被引：0
|
作者：
Ye, Yunfei [1 ]
Sun, Yin He Richard [1 ]
Fitzpatrick, Fidelma [2 ]
Greene, Catherine M. . [1 ]
机构：
[1] RSCI Univ Med & Hlth Sci, Dept Clin Microbiol, Lung Biol Grp, Dublin, Ireland
[2] RSCI Univ Med & Hlth Sci, Dept Clin Microbiol, Dublin, Ireland
来源：
FUTURE MICROBIOLOGY | 2024年 / 19卷 / 12期
关键词：
antibiotic enhancing; antimicrobial resistance; cystic fibrosis; ESKAPE pathogens; microRNA; Pseudomonas aeruginosa; Staphylococcus aureus; therapeutics;
D O I：
10.1080/17460913.2024.2357971
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：1041 / 1043
页数：3
相关论文
共 50 条
  • [41] Carrier-free combination for dry powder inhalation of antibiotics in the treatment of lung infections in cystic fibrosis
    Pilcer, Gabrielle
    De Bueger, Veronique
    Traina, Karl
    Traore, Hamidou
    Sebti, Thami
    Vanderbist, Francis
    Amighi, Karim
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 451 (1-2) : 112 - 120
  • [42] Local Administration of Polymyxins into the Respiratory Tract for the Prevention and Treatment of Pulmonary Infections in Patients without Cystic Fibrosis
    M. E. Falagas
    S. K. Kasiakou
    Infection, 2007, 35 : 3 - 10
  • [43] Cross-transmission Is Not the Source of New Mycobacterium abscessus Infections in a Multicenter Cohort of Cystic Fibrosis Patients
    Doyle, Ronan M.
    Rubio, Marc
    Dixon, Garth
    Hartley, John
    Klein, Nigel
    Coll, Pere
    Harris, Kathryn A.
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (09) : 1855 - 1864
  • [44] Failed Eradication Therapy of New-Onset Pseudomonas aeruginosa Infections in Children With Cystic Fibrosis Is Associated With Bacterial Resistance to Neutrophil Functions
    Kweng, Kelly
    Benedetti, Andrea
    Yau, Yvonne
    Waters, Valerie
    Nguyen, Dao
    JOURNAL OF INFECTIOUS DISEASES, 2022, 225 (11) : 1886 - 1895
  • [45] Association between the introduction of a new cystic fibrosis inhaled antibiotic class and change in prevalence of patients receiving multiple inhaled antibiotic classes
    Dasenbrook, Elliott C.
    Konstan, Michael W.
    VanDevanter, Donald R.
    JOURNAL OF CYSTIC FIBROSIS, 2015, 14 (03) : 370 - 375
  • [46] Ciprofloxacin-loaded lipid-core nanocapsules as mucus penetrating drug delivery system intended for the treatment of bacterial infections in cystic fibrosis
    Torge, Afra
    Wagner, Stefanie
    Chaves, Paula S.
    Oliveira, Edilene G.
    Guterres, Silvia S.
    Pohlmann, Adriana R.
    Titz, Alexander
    Schneider, Marc
    Beck, Ruy C. R.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 527 (1-2) : 92 - 102
  • [47] Cepacia syndrome in cystic fibrosis: A systematic review of the literature and possible new perspectives in treatment
    Dacco, Valeria
    Alicandro, Gianfranco
    Consales, Alessandra
    Rosazza, Chiara
    Sciarrabba, Calogero S.
    Cariani, Lisa
    Colombo, Carla
    PEDIATRIC PULMONOLOGY, 2023, 58 (05) : 1337 - 1343
  • [48] In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections
    Mario Mardirossian
    Arianna Pompilio
    Valentina Crocetta
    Serena De Nicola
    Filomena Guida
    Margherita Degasperi
    Renato Gennaro
    Giovanni Di Bonaventura
    Marco Scocchi
    Amino Acids, 2016, 48 : 2253 - 2260
  • [49] Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review
    M. C. Gaspar
    W. Couet
    J.-C. Olivier
    A. A. C. C. Pais
    J. J. S. Sousa
    European Journal of Clinical Microbiology & Infectious Diseases, 2013, 32 : 1231 - 1252
  • [50] Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC
    Lemaitre, Nadine
    Liang, Xiaofei
    Najeeb, Javaria
    Lee, Chul-Jin
    Titecat, Marie
    Leteurtre, Emmanuelle
    Simonet, Michel
    Toone, Eric J.
    Zhou, Pei
    Sebbane, Florent
    MBIO, 2017, 8 (04):
12345